Sirolimus Conversion Improves Survival After Heart Transplant

from TheBrief.Health · host TheBrief.Health

Sirolimus conversion offers selected heart transplant recipients potential long-term benefits, slowing cardiac allograft vasculopathy, preserving kidney function, reducing cancer risk, and improving survival.

Episode metadata supplied by the publisher feed · Published Aug 13, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Sirolimus Conversion Improves Survival After Heart Transplant

0:00 1:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on August 13, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!